Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience to Supply Reagents for Mayo/Medco Warfarin PGx Study

NEW YORK (GenomeWeb News) - Tm Bioscience said today that it will supply reagents to Medco Health Solutions and Mayo Collaborative Services for a joint clinical study of warfarin patients.
Under the agreement, Mayo and Medco will use Tm’s Tag-It reagents for P450-2C9 and VKORC1 in a study to determine whether genetic tests can cut costs and improve care for patients taking the blood-thinner warfarin.
In the study, originally announced in December, Medco and Mayo will perform genetic tests on 1,000 individuals taking warfarin, a common blood thinner used to prevent clotting in more than two million US patients each year.
The study aims to use the genetic tests to help physicians administer personalized dosages. One in five warfarin patients suffer “mild to severe” bleeding, said Mayo medical director Thomas Moyer.  
The study is expected to be complete by the end of 2007.
Tm president and CEO Greg Hines said warfarin testing is “a significant near-term opportunity” for the company’s pharmacogenetic business.
Financial terms of the agreement were not disclosed.
On Feb. 23, Tm shareholders will vote on whether to accept a stock-for-stock acquisition offer from Luminex, which hopes to expand the company’s reagent marketing opportunities through its international commercial network.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.